Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Valpimo 499.5mg/217.5mg Tablet CR

Prescription Icon
Prescription Required

Marketer

Mo-Siki Psychosciences

Salt Composition

Sodium Valproate (499.5mg) + Valproic Acid (217.5mg)

Overview Valpimo 499.5mg/217.5mg Tablet CR

Epileptic seizures, characterized by recurring fits and abnormal brain activity, are effectively managed by the dual-action medication, Valpimo 499.5mg/217.5mg CR tablet. This formulation calms nerve activity, thus preventing seizure episodes. Administered with food, the dosage is determined individually by your physician, potentially escalating gradually until your condition stabilizes. While therapeutic effects may take weeks to manifest, consistent use is crucial. Discontinuation, except under medical guidance, risks increased seizure frequency or exacerbation of bipolar symptoms (if present). Common side effects include nausea and tremors; less frequent reactions involve vomiting, headache, liver complications, and upper abdominal discomfort. Most side effects are transient, but persistent or bothersome symptoms warrant medical attention; mitigating strategies may be available. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, meningitis, depression, or suicidal ideation to your doctor. Comprehensive medication history, including contraceptives, is essential due to potential interactions. Pregnancy and breastfeeding necessitate careful consideration and potential dosage adjustments. Drowsiness or dizziness mandates abstention from driving or cycling. Regular blood tests monitor treatment efficacy. Alcohol consumption should be avoided due to potential side effect intensification. Weight gain is a possibility; a balanced diet, mindful snacking, and regular exercise are recommended. Report any atypical mood shifts, new or worsening depression, or suicidal thoughts or behaviors to your physician immediately.

Primary Ingredients of Valpimo 499.5mg/217.5mg Tablet CR

No text provided. Please provide the text you wish me to rephrase.

Uses of Valpimo 499.5mg/217.5mg Tablet CR

Seizure disorder

Major Benefits of Valpimo 499.5mg/217.5mg Tablet CR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Valpimo 499.5mg/217.5mg CR tablet whole; do not break, crush, or chew it. Administer this medication with food.

Common Side effects of Valpimo 499.5mg/217.5mg Tablet CR:

  • Nausea
  • Tremors

How to use Valpimo 499.5mg/217.5mg Tablet CR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Valpimo 499.5mg/217.5mg Controlled-Release tablet should be administered with a meal.

How Valpimo 499.5mg/217.5mg Tablet CR works:

Each Valpimo CR tablet (499.5mg/217.5mg) contains a dual anticonvulsant formulation of valproic acid and sodium valproate.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Valpimo 499.5mg/217.5mg Tablet CR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Valpimo tablets (499.5mg/217.5mg) pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Valpimo tablets (499.5mg/217.5mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Taking Valpimo 499.5mg/217.5mg CR tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can likely use Valpimo 499.5mg/217.5mg Tablet CR safely. Existing evidence indicates dose modification may be unnecessary, but medical advice is recommended. Individuals with pre-existing kidney conditions should discuss use with their physician.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when taking Valpimo 499.5mg/217.5mg CR tablets, as dose modification may be necessary. Medical advice is recommended. Valpimo 499.5mg/217.5mg CR tablets are unsuitable for patients experiencing severe or active liver disease.

What if you forget to take Valpimo 499.5mg/217.5mg Tablet CR :

Should you forget to take a Valpimo 499.5mg/217.5mg CR tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Valpimo 499.5mg/217.5mg Tablet CR

LabelValue
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System

FAQs on Valpimo 499.5mg/217.5mg Tablet CR

Valpimo 499.5mg/217.5mg CR Tablets may cause drowsiness. Refrain from driving, operating machinery, or engaging in hazardous activities until you know how this medication affects you. Report any drowsiness to your doctor.
Avoid alcohol while taking Valpimo 499.5mg/217.5mg Tablet CR, as it may worsen side effects.
Continue taking Valpimo 499.5mg/217.5mg Tablet CR as prescribed. Abruptly stopping the medication may worsen symptoms. Contact your doctor if you experience any problems while taking Valpimo 499.5mg/217.5mg Tablet CR.
Increasing the dosage beyond what's recommended won't necessarily improve results; it could lead to severe side effects and toxicity. If your symptoms aren't improving or are worsening despite taking the recommended dose, seek medical advice.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep out of reach of children, pets, and others.
Valpimo 499.5mg/217.5mg T...
99
MRP 115
13% off